GADOVIST 1.0 sol inj 5ml ser pré 5 ml

7680544232278 CH-54423 V08CA09 14.02.0.
GADOVIST 1.0 sol inj 5ml ser pré 5 ml
GADOVIST 1.0 sol inj 5ml ser pré 5 ml
1 / 2
google

Details

Product number
5442302
CPT
-
Packaging group
1 x 5 ml
Unit
Spritze(n)
Composition
gadobutrolum 604.72 mg corresp. 1 mmol, calcobutrolum, trometamolum, acidum hydrochloridum, aqua ad iniectabile ad solutionem pro 1 ml corresp. natrium max. 0.023 ml.

Articles (1)

Gadovist 1,0 mmol/ml, Injektionslösung
Injektionslösung
1 x 5 ml
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
18/07/2025
Professional SmPC
Français
18/07/2025
Professional SmPC
Italien
18/07/2025

Detailed composition

Substance Quantity Type Category
(N/A)
604.72 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI

Reimbursement information

Public price
CHF 66.05
Specialties list
Yes
Generic
No
SL addition date: 01/09/2006

Authorization holder

Bayer (Schweiz) AG

8045 Zürich

Authorization information

Swissmedic authorization number
54423
Drug name
Gadovist, Injektionslösung
Galenic form
LSINJ
ATC Code
V08CA09
Authorization status
Z
Dispensation category
B
First authorization
26/02/1998
Authorization expiration date
31/12/9999
IT number
14.02.0.
Domain
Human medicine
Field of application
Nierengängiges paramagnetisches Kontrastmittel für die Resonanztomographie (MRT)

Packaging details

Description (FR)
GADOVIST 1.0 sol inj 5ml ser pré 5 ml
Description (DE)
GADOVIST 1.0 Inj Lös 5ml Fertspr 5 ml
Market launch
26/02/1998
Narcotic (BTM)
No

Other packaging sizes

GADOVIST 1.0 sol inj 2ml flac 2 ml
1 x 2 ml FLAS
View
GADOVIST 1.0 sol inj 30ml flac 30 ml
1 x 30 ml FLAS
View
GADOVIST 1.0 sol inj 65ml fl 65 ml
1 x 65 ml FLAS
View
GADOVIST 1.0 sol inj 7.5ml ser pré 7.5 ml
1 x 7,5 ml SPRI
View
GADOVIST 1.0 sol inj 15ml ser pré 15 ml
1 x 15 ml SPRI
View